Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study

Seizure

Volumn 20, Issue 3, 2011, Pages 208-213

  Hu, Yida ^a   Huang, Yuanyuan ^a   Quan, Fengying ^a   Hu, Yuming ^a   Lu, Yang ^a   Wang, Xue Feng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Carbamazepine; Chinese epileptic patients; Long term; Retention; Valproate

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID;

ADULT; AGRANULOCYTOSIS; ALOPECIA; ARTICLE; CHINESE; CONTROLLED STUDY; DIZZINESS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HEART PALPITATION; HUMAN; HYPOTHYREA; LETHARGY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENSTRUATION DISORDER; MONOTHERAPY; NAUSEA; OBSERVATIONAL STUDY; PANCYTOPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; THYROID DISEASE; TREATMENT DURATION; TREMOR; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; EPILEPSIES, PARTIAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; OBSERVATION; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; VALPROIC ACID; YOUNG ADULT;

EID: 79952448512     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.11.020     Document Type: Article

References (29)

1. Y. Zhou, M. Liu, and W.N. Liang Progress on the epidemiological study of epilepsy Zhonghua Liu Xing Bing Xue Za Zhi 28 2007 92 94
2. M. Bialer, S.I. Johannessen, H.J. Kupferberg, R.H. Levy, P. Loiseau, and E. Perucca Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V) Epilepsy Res 43 2001 11 58 (Pubitemid 32008536)
3. M.J. Morrell Antiepileptic medications for the treatment of epilepsy Semin Neurol 22 2002 247 258 (Pubitemid 36042628)
4. M.J. Brodie, A. Richens, and A.W. Yuen Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group Lancet 345 1995 476 479
5. D.W. Chadwick, H. Anhut, M.J. Greiner, J. Alexander, G.H. Murray, and E.A. Garofalo A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77 Neurology 51 1998 1282 1288 (Pubitemid 28520544)
6. R. Kalviainen, M. Aikia, A.M. Saukkonen, E. Mervaala, and P.J. Riekkinen Sr. Vigabatrin vs. carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study Arch Neurol 52 1995 989 996
7. A.G. Marson, P.R. Williamson, H. Clough, J.L. Hutton, and D.W. Chadwick Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis Epilepsia 43 2002 505 513 (Pubitemid 34533706)
8. S. Hasan, M. Bahari, Z. Babar, and V. Ganesan Antiepileptic drug utilisation and seizure outcome among paediatric patients in a Malaysian public hospital Singapore Med J 51 2010 21 27
9. M.J. Brodie, E. Perucca, P. Ryvlin, E. Ben-Menachem, and H.J. Meencke Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy Neurology 68 2007 402 408 (Pubitemid 46208740)
10. J.A. French, A.M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, and C.L. Harden Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Neurology 62 2004 1252 1260 (Pubitemid 38526035)
11. A. Nicolson, R.E. Appleton, D.W. Chadwick, and D.F. Smith The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies J Neurol Neurosurg Psychiatry 75 2004 75 79 (Pubitemid 38091272)
12. M.J. Brodie, S.D. Shorvon, R. Canger, P. Halasz, S. Johannessen, and P. Thompson Commission on European Affairs: appropriate standards of epilepsy care across Europe.ILEA Epilepsia 38 1997 1245 1250 (Pubitemid 27481426)
13. M. Reunanen, M. Dam, and A.W. Yuen A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy Epilepsy Res 23 1996 149 155 (Pubitemid 26124783)
14. M.D. Privitera, M.J. Brodie, R.H. Mattson, D.W. Chadwick, W. Neto, and S. Wang Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy Acta Neurol Scand 107 2003 165 175 (Pubitemid 36398991)
15. D. Chadwick Better comparisons of antiepileptic drugs: what measures of efficacy? Pharm World Sci 19 1997 214 216 (Pubitemid 27450431)
16. E. Perucca Evaluation of drug treatment outcome in epilepsy: a clinical perspective Pharm World Sci 19 1997 217 222 (Pubitemid 27450432)
17. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy Epilepsia 39 1998 799 803
18. C.L. Gamble, P.R. Williamson, and A.G. Marson Lamotrigine versus carbamazepine monotherapy for epilepsy Cochrane Database Syst Rev 2006 CD001031
19. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy Epilepsia 22 1981 489 501
20. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy Epilepsia 30 1989 389 399
21. D. Schmidt, and L. Gram A practical guide to when (and how) to withdraw antiepileptic drugs in seizure-free patients Drugs 52 1996 870 874 (Pubitemid 26413298)
22. Y. Inoue, F. Nakamura, and T. Nishida Treatment guidelines for adult epilepsy Rinsho Shinkeigaku 44 2004 861 864 (Pubitemid 40013379)
23. A.G. Marson, A.M. Al-Kharusi, M. Alwaidh, R. Appleton, G.A. Baker, and D.W. Chadwick The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1016 1026 (Pubitemid 46436125)
24. A.G. Marson, A.M. Al-Kharusi, M. Alwaidh, R. Appleton, G.A. Baker, and D.W. Chadwick The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1000 1015 (Pubitemid 46436124)
25. D. Deleu, L. Aarons, and I.A. Ahmed Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients Arch Med Res 36 2005 49 53 (Pubitemid 40386348)
26. Y.J. Cho, K. Heo, W.J. Kim, S.H. Jang, Y.H. Jung, and B.S. Ye Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study Epilepsia 50 2009 1910 1919
27. R.H. Mattson, J.A. Cramer, and J.F. Collins A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group N Engl J Med 327 1992 765 771
28. M.C. Walker, and J.W. Sander The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal Neurology 46 1996 912 914 (Pubitemid 26134624)
29. S.M. LaRoche, and S.L. Helmers The new antiepileptic drugs: scientific review JAMA 291 2004 605 614 (Pubitemid 38500315)